---
figid: PMC3668835__JCI67963.f4
figtitle: Genomic landscape of small intestine neuroendocrine tumors
organisms:
- NA
pmcid: PMC3668835
filename: JCI67963.f4.jpg
figlink: /pmc/articles/PMC3668835/figure/F4/
number: F4
caption: Cancer therapeutics target multiple proteins in connected signaling cascades.
  Candidate therapeutically actionable genome alterations were noted in 72% of SI-NET
  patients. FLT3, fms-like tyrosine kinase receptor 3.
papertitle: The genomic landscape of small intestine neuroendocrine tumors.
reftext: Michaela S. Banck, et al. J Clin Invest. 2013 Jun 3;123(6):2502-2508.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9699807
figid_alias: PMC3668835__F4
figtype: Figure
organisms_ner:
- Homo sapiens
- Danio rerio
redirect_from: /figures/PMC3668835__F4
ndex: c1099eb3-dec8-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3668835__JCI67963.f4.html
  '@type': Dataset
  description: Cancer therapeutics target multiple proteins in connected signaling
    cascades. Candidate therapeutically actionable genome alterations were noted in
    72% of SI-NET patients. FLT3, fms-like tyrosine kinase receptor 3.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FLT3
  - FGFR2
  - PDGFRB
  - PDGFRA
  - ERBB2
  - PIK3CA
  - SRC
  - FGR
  - FYN
  - YES1
  - AKT1
  - AKT2
  - MTOR
  - flt3
  - fgfr2
  - erbb2
  - pik3ca
  - src
  - akt1
  - akt2
  - mtor
  - Temsirolimus
  - Enzastaurin
  - Pazopanib
  - Cancer
---
